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Glomerular hemodynamic changes vs. hypertrophy in
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Glomerular hemodynamic changes vs. hypertrophy in experimental
glomerular sclerosis. In a variety of recent studies in animals with
chronic renal diseases, investigators have found a tight correlation
between the elevation in glomerular pressures and flows versus glomer-
ular hypertrophy. To investigate a possible causal link between the
glomerular hyperfunction and hypertrophy, we studied the functional
and morphological sequelae of nephrectomy and those of unilateral
ureteral diversion (UD) into the peritoneal cavity (that is, removal of
renal clearance function while keeping the kidney tissue in situ). In all
nine experimental groups of 54 Munich-Wistar rats, 2/3 of the renal
mass was removed from the left kidney by ligation of two or three
branches f the left renal artery. In addition, right nephrectomy (NPX)
was performed in Groups lB. 2B and 3B or UD in Groups IC, 2C and
3C. The right kidney was left untouched in control groups, Groups IA,
2A and 3A. Micropuncture measurements and histological studies were
performed at four days (Groups IA, lB and IC), two weeks (Groups
2A, 2B and 2C) or four weeks (Groups 3A, 3B and 3C). At both four
days and two weeks, NPX and UD groups had marked and comparable
degrees of glomerular hypertension, hyperperfusion and hyperfiltration
compared to the control group in the left kidney. Whereas the maximum
planar area of glomeruli of the UD group assessed at four days
and two weeks by serial section histological analysis remained at a level
similar to that of the control group, PAmax was significantly increased in
the NPX group. At four weeks, similar degrees of glomerular hyper-
tension and hyperfiltration were again demonstrated in the left kidney of
NPX and UD groups. However, whereas glomerular sclerosis (0 to 4
scale) assessed at four weeks was subtle in the control group (mean:
0.02) and in the UD group (mean: 0.19), a significantly and markedly
higher sclerosis index (mean: 0.56) was noted in the NPX group. The
results indicate that I) physical loss of nephrons, in addition to loss of
their excretory function, is required to trigger glomerular hypertrophy
and sclerosis. 2) While glomerular hypertrophy appears to be an
important step preceding glomerular sclerosis, glomerular hyperfunc-
tion alone does little to induce glomerular hypertrophy and sclerosis.
During the past several years, a variety of experimental
studies have been designed and conducted in an attempt to
identify the mechanisms underlying the relentlessly progressive
nature of chronic renal diseases. The process of glornerular
sclerosis has, not surprisingly, been the focus of attention in
view of its ubiquitous presence in the wide range of human renal
diseases. Although we are far from understanding the details of
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the pathophysiologic processes occurring at the cellular level,
several phenomena have been claimed to be common to, and
preceding the glomerular sclerosis resulting from various pri-
mary diseases. Among them are proteinuria [1J, mesangial
deposition of macromolecules [2, 3], hyperlipidemia [4, 5],
intraglomerular coagulopathy [6, 7] and increased pressures and
flows at the glomerular level [8—10]. The theories are based on
the findings that the severity of these suspected intermediary
abnormalities varies in tight correlation with the degree of
glomerular sclerosis during experimental manipulations. De-
spite the impressively close correlation between glomerular
hypertrophy and sclerosis demonstrated in a number of exper-
imental settings, little attention has been focused on this pro-
cess. In fact, as described in detail in the Discussion section,
experimental maneuvers known to accelerate the glomerular
sclerosis, such as nephrectomy and high dietary protein intake,
induce glomerular hypertrophy before glomerular sclerosis be-
comes discernible.
Since the glomerular hypertrophy seen in these studies is
frequently associated with increased glomerular pressures and
flows, the possibility exists that the enhanced hemodynamics
are intermediary for the glomerular hypertrophy. In designing a
study to test this possibility, we have chosen to use the animal
models previously tested by Weinman et al [Ill. In their study,
whereas unilateral nephrectomy and ureteral diversion into the
peritoneal cavity were both found to increase whole kidney
GFR in the contralateral kidney, increase in kidney weight was
seen only following nephrectomy. We, therefore, tested whether
the increase in GFR seen after these surgical manipulations are
accompanied by increases in glomerular pressure and/or plasma
flow rate, and whether the hypertrophy seen only following
nephrectomy can be demonstrated at the glomerular level. If,
indeed, the hypertrophy seen by Weinman et al is demonstrated
at the glomerular level, quantitation of the degrees of glomeru-
lar hypertrophy and sclerosis at a more chronic phase of these
two models may determine the pathophysiological importance
of the glomerular hypertrophy as an intermediary step for the
sclerosis, in addition, such a histological quantitative compar-
ison between these two models at the glomerular level would
also provide an opportunity to examine the role of elevated
glomerular pressures and flows as intermediary mechanisms if
these hemodynamic changes indeed occurred to comparable
degrees after nephrectomy and ureteral diversion.
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Nephrectomy Ureteral Diversion
Group 1A(4 days) Group lB (4 days) Group 1C (4 days)
Group 2A (2 weeks) Group 2B (2 weeks) Group 2C (2 weeks)
Group 3A (4 weeks) Group 3B (4 weeks) Group 3C (4 weeks)
Fig. 1. Experimental protocol of the present study. All left kidneys
(drawn on the right side in each panel) were subjected to 2/3 nephrec-
tomy, while right kidneys were untouched (Groups IA. 2A and 3A),
nephrectomized (Groups lB. 2B and 3B) or ureter-diverted (Groups IC,
2C and 3C). Micropuncture measurements and histological studies were
performed in the left kidney at 4 days (Groups IA, lB and IC), 2 weeks
(Groups 2A, 2B and 2C) and at 4 weeks (Groups 3A, 3B and 3C).
Methods
Experimental groups
Fifty-four Munich-Wistar rats (body weight 180 to 230 g)
were used in nine experimental groups. Unilateral nephrectomy
in Groups IB, 2B and 3B or ureteral diversion in Groups IC, 2C
and 3C was performed on the right kidney in accord with the
procedure described below, while the right kidney was left
untouched in the control Groups IA, 2A and 3A (Fig. 1). In all
groups, 2/3 of the left kidney was infarcted by ligation of two or
three branches of the left renal artery. These procedures were
performed under anesthesia with sodium pentobarbital (Nem-
butal, Abbott Laboratories, North Chicago, Illinois, USA; 25 to
30 mg/kg body wt, i.p.). The animals were returned to cages
after recovery from anesthesia and allowed water and regular
rat chow (Wayne Lab-blox, Wayne Research Animal Diets,
Chicago, Illinois, USA) ad lib until the time of study. Micro-
puncture measurements and histological studies were per-
formed on the left kidney at four days (Groups IA, lB and IC),
at two weeks (Groups 2A, 2B and 2C) or four weeks (Groups
3A, 3B and 3C).
Unilateral nephrectomy (NPX; Groups IB, 2B and 3B). The
right adrenal gland and renal capsule attached to the surround-
ing tissue were separated from the right kidney. The right renal
artery, vein and ureter were tied at the renal pedicle, and the
right kidney was removed. Care was taken to avoid damaging
the adrenal gland.
Ureteral diversion (UD; Groups IC, 2C and 3C). The ureter
was cannulated with a polyethylene catheter (PE-50, Clay
Adams, Parsippany, New Jersey, USA) and sutured to the
peritoneum and muscle. The distal end of the catheter was
placed into the peritoneal cavity allowing urine to drain freely
into the peritoneal cavity. The distal segment of the ureter was
ligated.
Micropuncture studies
All animals were anesthetized with mactin (Byk, FRG; 100
mg/kg body wt, i.p.) and surgically prepared in a fashion
routinely performed in our laboratory for micropuncture exper-
iments [12, 131. Briefly, following tracheostomy, a polyethylene
catheter (PE-50) was placed into the left jugular vein for
subsequent infusion of plasma and inulin. The left femoral
artery was also catheterized for monitoring mean arterial pres-
sure (MAP) and for periodic blood collections. MAP was
measured by an electronic transducer (model p23Db, Gould
Inc., Cleveland, Ohio, USA) connected to a recorder (model
2400S, Gould Inc.). Laparotomy was then performed. The left
ureter was catheterized with a polyethylene tube (PE-lO) for
subsequent urine collection, and the left kidney was immobi-
lized for micropuncture study. Ten percent inulin in 0.9% NaCI
solution was infused i.v. with a priming volume of 0.5 ml,
followed by constant infusion at a rate of 0.4 to 1.0 mI/hr. To
maintain the circulating plasma volume at the normal euvolemic
level during the experiment, each rat received isooncotic rat
plasma as described previously [12].
Micropuncture measurements and collections were made on
the left kidney in all nine groups to determine single nephron
glomerular filtration rate (SNGFR), mean glomerular capillary
hydraulic pressure (P0), proximal tubule hydraulic pressure
(PT) and mean transcapillary hydraulic pressure difference (P).
In addition, in Groups lA, lB. IC, 2A, 2B and 2C, surface
efferent arteriolar hydraulic pressure (RE), femoral arterial (CA)
and efferent arteriolar (CE) plasma protein concentration, single
nephron filtration fraction (SNFF), initial glomerular capillary
plasma flow rate (QA). ultrafiltration coefficient (Kf), as well as
resistances of single afferent (RA) and efferent (RE) arteriole
were obtained)
For the measurement of SNGFR, exactly timed (Ito 2 mm)
samples of tubule fluid were collected from surface proximal
convolutions of two or three nephrons for determination of flow
rate and inulin concentration. Coincident with these tubule fluid
collections, two or three samples of femoral arterial blood were
obtained for determination of hematocrit and plasma concen-
tration of protein and inulin. These measurements permit cal-
culation of SNGFR. For the measurements of P0, T and P,
timed-averaged pressures were recorded in surface glomerular
capillaries, proximal tubules, and surface efferent arterioles
with a continuous recording, servo-null micropipette transducer
system (model 4A, Instrumentation for Physiology and Medi-
cine, San Diego, California, USA). Micropipettes with outer tip
diameters of —2 /.un and containing 2.0 M sodium chloride were
used. Hydraulic output from the servo-null system was coupled
electronically to a channel of the direct-writing recorder (Re-
corder 2400S, Gould Inc.) by means of a pressure transducer.
Colloid osmotic pressure (ir) of plasma entering and leaving
glomerular capillaries was estimated from values for protein
concentration (C) in femoral arterial (CA) and surface efferent
arteriolar (CE) blood plasma samples, by using the equation
derived by Deen et al [14, 15]. Values for CA and thus ITA for
The computation of various indices for glomerular microcirculatory
dynamics is performed based on micropuncture measurements obtained
from different nephrons. The existence of heterogeneity of function
among nephrons in remnant kidneys four weeks after subtotal nephrec-
tomy (Groups 3A, 3B and 3C) is likely to cause an incorrect estimation
of the various parameters which can be obtained only by this compu-
tation [34], thereby precluding meaningful intergroup comparison of
many of the parameters. Therefore, in Groups 3A, 3B and 3C animals
only SNGFR, P and P1. which can be assessed directly by micro-
puncture, were ascertained.
Control
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femoral arterial plasma are taken as representative of values of
C and ii for the afferent end of the glomerular capillary network.
These estimates of preglomerular and postglomerular plasma
protein concentration permit calculation of SNFF and Kf, as
well as RA, RE and QA' by using equations given below. In
addition to these micropuncture measurements, a timed urine
sample was taken for the assessment of whole kidney glomer-
ular filtration rate (GFR).
Light microscopic studies
After the micropuncture studies, the left kidneys were har-
vested and fixed with 10% buffered formalin. Histological
studies were performed at the light microscopic level on sec-
tions stained with periodic acid-Schiff by a pathologist (A.F.) in
a blind fashion. Maximum planar area of glomeruli (described
below) was determined for individual glomeruli by examining 10
to 20 serial thin sections for each glomerulus at four days in
Groups IA, lB and 1C and at two weeks in Groups 2A, 2B and
2C. Glomerular sclerosis was semiquantitated on the whole
kidney level on coronal sections at four weeks in Groups 3A, 3B
and 3C.
Maximum planar area of glomeruli (PAmax). Serial thin sec-
tions (3 jim) were made and the same glomerulus was traced
serially to obtain PAmax using a computerized planimeter (Mi-
cro-plan II, Donsanto Corp., Natick, Massachusetts, USA). A
minimum of 20 randomly chosen glomeruli was measured from
surface through the deep cortex, and a mean value of PAmax
from each animal was calculated.
Sclerosis index. Glomerular sclerosis was assessed by a
semiquantitative score (sclerosis index, grade 0 to 4), using the
methods of Raij, Azar and Keane [16], where grade I represents
involvement of up to 25% of the glomerulus, while grade 4
represents sclerosis of 75 to 100% of the glomerulus. The whole
kidney sclerosis index was obtained by averaging scores for all
glomeruli on one or two of the coronal sections, containing a
minimum of 100 glomeruli.
Other histologic abnormalities, such as tubular changes,
interstitial changes and vascular changes were documented
non-quantitatively.
Analytic
Plasma and urine concentration of inulin was determined by
the anthrone method [17], Details of the analytical procedures
for inulin determination in nanoliter samples and CA and CE
measurements in samples obtained during micropuncture stud-
ies are given elsewhere [18, 19].
Calculation and satisiics
Based on the data obtained from micropuncture studies,
SNGFR, SNFF, QA. RA, RE and P were calculated using
equations as described below. Single nephron glomerular filtra-
tion rate was calculated as
SNGFR - (TF/P)1 ' V
where (TF/P)1 and VTF refer to the tubule fluid to plasma inulin
concentration ratio and tubule fluid flow rate, respectively.
Single nephron filtration fraction was calculated as
SNFF = 1 — (CA/CE)
where CA and CE denote afferent and efferent arteriolar plasma
protein concentrations, respectively.
Initial glomerular capillary plasma flow rate, QA, was calcu-
lated as
QA = SNGFRJSNFF
Blood flow rate per single glomerulus was calculated as
GBF = QAIU — HctA)
(3)
(4)
where HctA, the hematocrit of afferent arteriolar blood, is taken
as equal to femoral arterial hematocrit.
Efferent arteriolar blood flow rate was calculated as
EABF = GBF — SNGFR
Resistance per single afferent arteriole was calculated as
RA = (MAP — P0)/GBF
Resistance per single efferent arteriole was calculated as
RE = (PGc — PE)/EABF
(5)
(6)
(7)
Mean glomerular transcapillary hydraulic pressure difference
was calculated as
= cc — PT (8)
The ultrafiltration coefficient, Kf, was calculated with a
differential equation that gives the rate of change of protein
concentration with distance along an idealized glomerular cap-
illary. This equation, together with its derivation and the
method for its solution, has been given in detail elsewhere [15].
Results are expressed as mean SEM. Data from multiple
groups were compared using one-way ANOVA followed by
multiple comparisons by the Bonferroni method [20]. Statistical
significance was defined as P value <0.05.
Results
Animal and whole kidney data
Average values for body weight, MAP, GFR and the weight
of the left kidney at the time of sacrifice are summarized in
Table 1. Body weight measured at four days or two weeks was
not significantly different among groups. At four weeks, values
for body weight in Group 3A control rats (average: 272 6 g)
were significantly higher than those in Group 313 NPX rats
(average: 227 18 g) or Group 3C UD rats (average: 230 4 g),
while Group 3B and 3C were essentially identical in this regard.
Values of MAP at two weeks showed mild hypertension in
Groups 2A, 2B and 2C. At four weeks, values for MAP in
Group 3B NPX and Group 3C UD rats were significantly and
substantially higher than those in Group 3A control rats (168
10 mm Hg and 156 5 vs. 122 8). Whole kidney GFR values
(1) determined in the left kidneys of NPX rats and UD rats were
markedly and comparably elevated above control levels at four
days, two weeks as well as at four weeks. The NPX rats had left
wet-kidney weight markedly higher than that of the control rats
at four days, two and four weeks, whereas wet-kidney weight of
(2) UD rats was significantly but modestly increased at four
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Table 1. Animal and whole kidney data
Left
Body Left whole wet-kidney
weight MAP kidney GFR weight
N g mmHg mi/mm g
4 Days
Group 1A control
Group lB NPX
Group IC UD
6
6
6
193 5
194 4
182 4
113 6
126 9
114 4
0.11 0.04
0.36 0,05"
0.30 0.02"
0.92 0.05
1.17 005b.d
0.92 0.05
2 Weeks
Group 2A control 6 222 4 131 8 0.23 0.02 0.68 0.04
Group 2B NPX 6 203 8 147 9 0.39 0.04a 1.00 0.05C
Group 2C UD 6 216 9 138 8 0.46 0.05 0.86 0.08
4 Weeks
Group 3A control
Group 3B NPX
6
6
272 6
227 l8 122 8168 10b 0.26 0.030.44 0.05a 0.60 0.031.17 0.1l
Group 3C UD 6 230 4C 156 5 0.48 0.05" 0.98 0.06C
Values are expressed as mean I SEM. Abbreviations are: MAP, mean systemic arterial pressure; control, left 2/3 kidney infarction only; NPX,
left 2/3 kidney infarction + right nephrectomy; UD, left 2/3 kidney infarction ÷ right ureteral diversion.
a P < 0.05
b P < 0.025
P< 0.0025, significant difference from those of control groups (Group IA, Group 2A or Group 3A) by simultaneous multiple comparisons with
the Bonferroni method following one-way ANOVA.d P < 0.025, significant difference between Group lB vs. IC.
Table 2. Summary of various glomerular microcirculatory parameters at 4 days and 2 weeks
N
SNGFR
ni/mm
POC P
(m,n Hg)
QA
ni/mm
CA
g/dI
RA RE Kf
n!/(min/
mm Hg) SNFFmm Hg/(ni/mmn)
4 Days
Group IA 6 26 3 53 I 39 1 106 20 6.2 0.4 0.33 0.04 0.25 0.05 2.46 0.30 0.27 0.03
control
Group lB NPX 6 38 2" 61 2" 48 2C 166 22C 6.2 0.1 0.20 0.02a 0.17 0.02 1.86 0.12 0.24 0.02
Group IC UD 6 37 1" 65 2C 52 4C 170 34b 6.3 0.1 0.17 0.03" 0.20 0.04 1.56 0.06 0.24 0.03
2 Weeks
Group 2A 6 40 3 52 2 38 2 146 13 6.1 0.2 0.29 0.03 0.16 0.02 5.58 0.96 0.28 0.02
control
Group 2B NPX 6 61 4" 66 3C 53 2C 274 18C 6.4 0.1 0.17 0.02" 0.11 0.01 2.52 0.18" 0.22 0.01
Group 2C UD 6 61 4" 70 3C 57 3C 270 27k' 6.2 0.2 0.14 0.02" 0.13 0.02 2.10 0.30" 0.23 0.03
Abbreviations are: SNGFR, single nephron glomerular filtration rate; GC, mean glomerular capillary hydraulic pressure; P, mean glomerular
transcapillary hydraulic pressure difference; QA. initial glomerular capillary plasma flow rate; CA, afferent arteriolar plasma protein concentration;
RA, afferent arteriolar resistance; RE, efferent arteriolar resistance; Kf, ultrafiltration coefficient; SNFF, single nephron filtration fraction.
Efferent arteriolar colloid osmotic pressure-to-glomerular transcapillary hydraulic pressure difference ratio was found to be less than 1.0 in 4
Group IA rats, 6 Group lB rats, 6 Group IC rats, 5 Group 2A rats, 6 Group 2B rats and 6 Group 2C rats. In these animals, unique Kf values were
calculated, and were pooled with minimum Kf values to obtain average values.
Values are expressed as mean 1 SEM.
a P < 0.05, b p < 0.025, P < 0.0025, significant difference from control Group IA or 2A by simultaneous multiple comparisons with the
Bonferroni method following one-way ANOVA.
weeks.2 The right diverted kidney of the UD rats at four days
and two weeks showed no or only mild calyceal dilatation. At
four weeks there was distinctive hydronephrosis, that is, mod-
erately enlarged calyces and thinning of renal parenchyma.
Micropuncture studies at four days and two weeks
As shown in Table 2, both Group lB NPX and Group IC UD
rats studied at four days demonstrated comparable degrees of
elevations in SNGFR (38 2 nI/mm and 37 1), glomerular
capillary hydraulic pressure, P0, (61 2 mm Hg and 65 2),
2 Since only wet kidney weight was measured, some differences
among groups may reflect not only tissue mass but also changes of
extracellular fluid volume, that is, blood and tubule fluid.
glomerular transcapillary hydraulic pressure difference, zP (48
2 mm Hg and 52 4), and glomerular plasma flow rate, QA
(166 22 nI/mm and 170 34) above Group IA control levels.
Although values for efferent arteriolar resistance, RE, were not
different among the three groups, those of afferent arteriolar
resistance, RA, were substantially decreased in NPX and UD
rats, averaging 0.20 0.02 mm Hg/(nl/min) and 0.17 0.03,
values markedly lower than the average obtained in the control
rats [0.33 0.04 mm Hg/(nl/min)]. Ultrafiltration coefficient,
Kf, was also significantly lower in both Group lB NPX and
Group IC UD rats than in Group IA control rats [1.86 0.12 nIl
(mm/mm Hg) and 1.56 0.06 vs. 2.46 0.30].
By two weeks the degrees of elevations in glomerular pres-
sures and flows in NPX and UD rats became even more
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Group3A Group3B Group3C Group3A Group3B Group3C
Fig. 2. SNGFR andglomerular transcapillary hydraulic pressure dif-
ference, P, at 4 weeks (Groups 3A, 3B and 3C). Similar degrees of
glomerular hypertension and hyperfiltration were demonstrated in the
NPX and UD groups.
Fig. 4. Sclerosis index at 4 weeks (Groups 3A, 3B and 3C). The
sclerosis index of NPX (3B) was significantly higher than those of the
UD (3C) and control (3A) groups.
Group 1A Group lB Group 1C Group 2A Group 28 Group 2C
Fig. 3. Maximum planar area of glomeruli, PA,,,,,, , at 4 days (Groups
IA, lB and IC) and at 2 weeks (Groups 2A, 2B and 2C). The average
values of PAm,, in lB and 2B NPX groups were significantly higher than
those of the corresponding 1C and 2C UD groups and lA and 2A control
groups.
marked, however, the magnitude of the abnormalities remained
comparable in NPX versus UD rats. Thus, as shown in Table 2,
SNGFR and QA of Group 2B (61 4 nllmin and 274 18 nIl
mm) and Group 2C (61 4 nl/min and 270 27) were markedly
higher than those of Group 2A (40 3 and 146 13); so were
PGC and i.P (66 3 mm Hg and 53 2 mm Hg, 70 3 and 57
3 versus 52 2 and 38 2). Similar to those measured at four
days, values for RA of Group 2B NPX 0. 17 0.02 mm HgI(nlI
mm)] and Group 2C UD rats (0.14 0.02) were substantially
below Group 2A control levels (0.29 0.03). K1 values mea-
sured at two weeks in Group 2B NPX and Group 2C UD rats
were again comparable and far below Group 2A control levels.
Micropuncture studies at four weeks
As shown in Figure 2, in Group 3B NPX and Group 3C UD
rats, there were marked and comparable increases in both
SNGFR (69 5 nllmin and 68 4) and P (51 2 mm Hg and
51 1) over Group 3A control values (SNGFR: 44 3 nI/mm;
P:38 1 mm Hg).
Light microscopic studies at four days and two weeks
As shown in Figure 3, there was no significant difference in
values for maximum planar area of glomeruli, PAmax, between
Group IA control and Group IC UD rats (8.2 0.2 x i— mm2
vs. 8.7 0.3) measured at four days or between Group 2A
control and Group 2C UD rats (8.5 0.6 vs. 10.0 0.6).
However, the mean PAma,, of both Group lB and 2B NPX rats
(11.3 0.3 and 12.7 0.4) was significantly higher than in
corresponding Group lA and 2A control rats, as well as in
Group 1C and 2C UD rats. In Group 2B NPX rats, there was a
wide variability in PAmax within each kidney, that is, standard
error of mean PAmax determined for each animal in this group
was, on average, almost twice that of control rats (0.43 vs.
0.26). Glomerular sclerosis and hyalinosis and other features
such as interstitial lesions were minimal in all groups assessed
at four days or two weeks.
Light microscopic studies at four weeks
As shown in Figure 4, the sclerosis index of Group 3C UD
rats was only slightly, although significantly, higher than that of
Group 3A control rats (0.19 0.04 vs. 0.02 0.01). The
sclerosis index of Group 3B NPX rats (0.56 0.08) was not
only significantly but also substantially higher than that of
Group 3A control and Group 3C UD rats. Epithelial cell
adhesion to Bowman's capsule, PAS positive protein deposi-
tion in epithelial cells and various degrees of interstitial changes
(that is, tubular atrophy and dilatation and interstitial lym-
phocytic infiltrate with minimal fibrosis) were observed in all
Group 3B NPX rats and some Group 3C UD rats. There were
no significant arterial or arteriolar changes in any of Groups 3A,
3B and 3C.
Discussion
In the present study, both removal of the kidney or diversion
of the ureter into the peritoneal cavity were found to cause
glomerular hypertension, hyperperfusion and hyperfiltration in
remarkably similar degrees at four days and at two weeks in
nephrons of the contralateral kidney. Thus, the levels ofP, QA
and SNGFR were comparably and substantially higher in
Group B and C rats than in Group A control rats. The patterns
in the remnant glomeruli of Group B rats were essentially
identical to those found by others in rats following similarly
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extensive nephrectomy, that is, removal of —5/6 of total renal
mass [9, 10]. The high glomerular pressure and flow found in
Group B NPX and Group C UD rats were attributed to the
dilative adjustments made within the glomerular microcircula-
tory vessels which, again, occurred in remarkably similar
fashions following these two forms of surgical manipulations.
Thus, a marked and comparable preferential fall in afferent
arteriolar resistance was found in both Groups B and C.
Although the level of glomerular plasma flow was not assessed
four weeks after the surgical preparations, our micropuncture
measurements in Groups 3A, 3B and 3C revealed that both
glomerular capillary hydraulic pressure and filtration rate re-
mained at similarly elevated levels in NPX and UD rats
compared to control levels.
In contrast to these similarities in glomerular hemodynamic
pattern between NPX versus UD groups, a marked difference
was noted between these groups in the size of glomeruli. Thus,
marked glomerular hypertrophy was observed only in NPX and
not in UD rats.3 The observed dissociation between the en-
hanced glomerular hemodynamic pattern and the glomerular
size in UD rats speaks against the notion that the correlation
between the enhanced glomerular hemodynamics and the gb-
merular hypertrophy, demonstrated following subtotal nephrec-
tomy in the present and many other studies, reflects a causal
relationship between the two phenomena.4 Although statisti-
cally insignificant, average PAmax of UD rats was numerically
somewhat higher than that of controls. Our results thus do not
rule out the possibility that a subtle glomerular hypertrophy
indeed occurred in UD kidney, yet undemonstrable statistically
due to the limited sensitivity of our morphometric method or to
the small number of animals studied, or that such a relatively
minor degree of glomerular hypertrophy was caused by the
enhanced hemodynamic pattern. In this regard, the possibility
exists that this numerical but statistically insignificant enlarge-
ment of average PAmax in UD rats reflects the variable degree of
hydronephrosis seen in the ureter-diverted kidneys, which, as a
result of their thinning of cortex and reduced nephron popula-
tion, would have imposed a hypertrophic stimulus on the
glomeruli of the contralateral kidney.5 Indeed the UD rat which
We assessed glomerular size only at four days and two weeks. The
recent study employing morphometry on the entire corpuscle of the
individual glomeruli [321 demonstrated that the size of the glomeruli
increases along with the degree of sclerosis at early stages; however,
the glomerulus becomes smaller when sclerosis advances. In designing
the present study, therefore, it was felt that the PAmax determined for
whole kidney at four weeks of NPX rats (therefore including both
expanding and shrinking glomeruli) would become an inaccurate
marker for the degree of the glomerular hypertrophy since the value
would likely be dampened considerably by the advanced sclerotic
process which followed the hypertrophy.
One may argue, however, that the enhanced glomerular hemody-
namics are indeed an inducer of glomerular hypertrophy, yet this
inducing effect is dampened in the left kidney of UD rats by some
unknown influences imposed upon the right kidney (such as the
presence of urine in the peritoneal cavity), or directly on the left kidney.
Hydronephrosis has been shown to cause hypertrophy of the
contralateral kidney (36, 37). Thus, the hydronephrosis which was seen
in various degrees in ureteral diverted kidneys of Groups 2C and 3C,
through nephron population loss as evidenced by the thinning of the
cortex, may have induced the hypertrophy of the glomeruli in the
contralateral kidney in the UD animals.
had the most severe hydronephrosis of the right ureter-diverted
kidney had the largest glomeruli (average PAmax: 11.5 x iO
mm2) in the left kidney.
While the present study, to our knowledge, has become the
first demonstration of the absence of correlation between en-
hanced hemodynamic pattern and hypertrophy at the level of
the glomerulus, we found in the present experiment an exist-
ence of correlation between glomerular hypertrophy and scle-
rosis, which has been observed by others in a variety of
experimental settings. Indeed, unilateral nephrectomy, which
imposes a hypertrophic stimulus on the remnant kidney and
glomeruli, has been found to accelerate the glomerular scleros-
ing process in experimental models of glomerulonephritis [21]
and minimal change disease [221. It is well known in both animal
and human forms of diabetes mellitus that marked renal and
glomerular hypertrophy precedes the development of diabetic
nephropathy [23, 24]. When Goldblatt hypertension is induced
by partial constriction of the unilateral renal artery in diabetic
rats, acceleration of glomerulopathy occurs in the contralateral
kidney [25, 26]. Glucocorticoid, which is known to accelerate
gbomerulosclerosis in subtotally nephrectomized rats, is known
as a potent inducer of renal hypertrophy [27] and suppressor of
collagenase [28]. Other maneuvers which modify the degree of
glomerubosclerosis in various animal models also affect the
degree of the accompanying glomerular hypertrophy. Thus,
high and low protein-content diet feedings, which modulate
glomerular size in normal animals [29], augment and attenuate,
respectively, the glomerubopathy seen following nephrectomy
[30] or streptozotocin administration [31]. Administration of an
angiotensin I converting enzyme inhibitor also markedly atten-
uates the glomerular hypertrophy along with the diminution of
glomerulosclerosis [9].
Such a tight correlation between glomerular hypertrophy and
sclerosis has been demonstrated at the single nephron level, as
well. Our most recent preliminary study using thin-section
histological analysis revealed that within a given remnant
kidney of a subtotally nephrectomized animal, strong correla-
tion exists between the degree of glomerular sclerosis and the
glomerular size [32]. Of interest in this regard, is a recent finding
obtained in human specimens that the kidney with focal gb-
merular sclerosis is characterized by having a substantially
larger glomerular size when compared to those of age-matched
normal individuals and of patients with minimal change ne-
phrotic syndrome [33]. While lack of correlation between
enhanced glomerular hemodynamics and sclerosis has been
observed in several experimental settings [34, 35], there has not
been a single experimental demonstration where hypertrophy
and sclerosis are dissociated. As was the case for the hemody-
namic-scierosis correlation, then, it appears legitimate, until
proven otherwise, to regard this tight correlation between
hypertrophy and sclerosis as reflecting pathophysiologically
linked processes, which take place in the progressive destruc-
tion of glomerular architecture in renal diseases.
In summary, although comparable degrees of glomerular
hypertension and hyperfiltration were demonstrated at four
days, two and four weeks in the NPX and UD groups, the NPX
group showed significantly and substantially greater degrees of
gbomerular hypertrophy and sclerosis than the UD and control
groups. These data indicate that while gbomerular hypertrophy
appears to be an important step preceding glomerular sclerosis,
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glomerular hyperfunction alone does little to the induction of
hypertrophy and sclerosis. The results also indicate that the
physical loss of nephrons, not the loss of their excretory
function alone, is required to trigger glomerular hypertrophy
and sclerosis. Further investigations seeking specific factors
which induce glomerular hypertrophy and the possible mecha-
nism whereby the hypertrophic process may cause sclerosis,
should elucidate the mechanism of the progression of chronic
renal diseases.
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